SCHEMBL10242653

SCHEMBL10242653

CCn1c(=O)n(CC(C)=O)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.59
ALDH1A1 P00352 5/20 0.58
GAA P10253 2/20 0.54
NPC1 O15118 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
POLB P06746 2/20 0.47
THRB P10828 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 5/20 0.46
HTT P42858 1/20 0.46
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
HPGD P15428 1/20 0.45
RECQL P46063 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16688540 0.86 APEX1 (0.56) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL5329443 0.86 APEX1 (0.82) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL4621924 0.84 ALDH1A1 (0.59) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL13332552 0.79 MAPT (0.61) APEX1ALDH1A1SMN1; SMN2POLBKDM4E
SCHEMBL9631422 0.76 ALDH1A1 (0.50) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL22700984 0.76 HTT (0.69) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL5324208 0.76 ALDH1A1 (0.67) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL6909959 0.76 PGR (0.53) ALDH1A1GAAKDM4EMAPTGFER
SCHEMBL5328824 0.76 ALDH1A1 (0.58) APEX1ALDH1A1GAANPC1MEN1
SCHEMBL3301756 0.75 TMEM97 (0.51) APEX1ALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148373-B2 Compounds ASTRAZENECA AB (SE) 2012-04-03 US disclosed
US-20090298807-A1 Compounds ASTRAZENECA AB (SE) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298807-A1 Compounds PKD1, SLC10A1, ABCB11 APEX1 4101/4885ALDH1A1 102/4885GAA 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.